ArticleTheranostics2022

The peroxisome proliferator-activated receptor agonist rosiglitazone specifically represses tumour metastatic potential in chromatin inaccessibility-mediated FABP4-deficient gastric cancer.

Qi-Yue Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.